$MBAI

MBody AI Ltd.

Check-Cap is an Israeli company headquartered in Isfiya. Its historical business is clinical-stage medical diagnostics, including C-Scan, a capsule-based colorectal screening system designed to detect polyps using ultra-low-dose X-rays. C-Scan comprises an ingestible scanning capsule, wearable tracking equipment and software for reviewing colon data. Check-Cap has discontinued development of C-Scan and focuses its current operations on pursuing strategic options and maintaining previously manufactured inventory. Check-Cap has agreed to merge with MBody AI, which designs, integrates and manages AI-enabled robotic and software systems for large commercial environments, including hotels, casinos and convention centers. MBody AI combines its AI Orchestrator software platform with third-party robotic equipment, providing turnkey deployment and operational management to enterprise customers. It makes money through platform subscriptions, AI-enabled services, deployment and support, maintenance and warranty services, and delivery of third-party hardware. Check-Cap also holds exclusive Ghost Kitchen area representative rights in New Jersey, entitling it to a share of franchise fees and ongoing royalties.

No enriched coverage for $MBAI in the last 7 days.

No SEC Form 4 filings for $MBAI in the last 30 days.

See all $MBAI insider activity →

MBody AI Adds 2 Patents Pending for Its Enterprise AI Workforce Platform

MBody AI (NASDAQ: MBAI) announced two new patent applications for its Orchestrator platform, which integrates autonomous equipment from multiple manufacturers. The platform offers AI-as-a-Service, generating recurring revenue through long-term customer agreements. The company aims to expand its capabilities and international presence, with Morgan Stanley estimating a $5 trillion market for humanoid robots by 2050.

MBAI sentiment & insider activity

Recent MBAI coverage spans technology, mergers & acquisitions and corporate actions.

What's driving MBAI

  • MBody AI Ltd. (MBAI) has signed a multiyear partnership with Caribe Royale Orlando, its first non-casino and Florida-based resort for its AI Orchestrator platform. This expands MBody's resort footprint beyond casino properties.

    tradingview.com · Oct 22, 2026

  • Patent filings support the defensibility of Orchestrator and its ability to operate in harsher outdoor conditions, a modest positive for the platform narrative.

    globenewswire.com · Oct 8, 2026

  • The financing and contract provide fresh capital and revenue visibility, likely supporting the stock price.

    sina.com.hk · Sep 29, 2026

  • Potential upside for MBAI as the software addresses a key interoperability gap in robotics, expanding addressable market.

    benzinga.com · Sep 25, 2026

  • The contract validates MBody AI's technology and could drive near‑term revenue growth and market visibility.

    intelligencer.ca · Sep 9, 2026

AlphAI scores every news story that mentions MBAI with an AI model for sentiment and relevance, and aggregates insider trades from MBody AI Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $MBAI

Score

MBody AI Adds 2 Patents Pending for Its Enterprise AI Workforce Platform

MBody AI (NASDAQ: MBAI) announced two new patent applications for its Orchestrator platform, which integrates autonomous equipment from multiple manufacturers. The platform offers AI-as-a-Service, generating recurring revenue through long-term customer agreements. The company aims to expand its capabilities and international presence, with Morgan Stanley estimating a $5 trillion market for humanoid robots by 2050.

MBody AI Advances AI Robotics Rollout at Mohegan Sun

MBody AI (NASDAQ: MBAI) completed a successful pilot of its autonomous robots at Mohegan Sun, transitioning to a paid commercial agreement. Mohegan Sun plans to expand the robot deployment under a multi-year subscription agreement. The company's technology aims to handle repetitive tasks, allowing staff to focus on higher-value work.

Check-Cap Advances MBody AI Merger; Reverse Share Split

Check-Cap Ltd. (NASDAQ: MBAI) said it will implement a 1-for-7 reverse share split on Aug. 13, 2026 to prepare for its proposed merger with MBody AI Corp. The company aims to meet Nasdaq’s $4.00 minimum bid requirement for an initial listing application, with merger closing targeted for Q3 2026, subject to conditions. Shares will trade under MBAI on a split-adjusted basis.

Check-Cap: MBody AI Takes Autonomous Services Outdoors, Expanding Addressable Market

Check-Cap Ltd. (NASDAQ: MBAI) said MBody AI, involved in a proposed business combination, secured exclusive U.S. distribution rights for outdoor cleaning robots in gaming and large hotels and resorts across six states. The company cited a real-world pilot with a major U.S. operator and said the Orchestrator platform can coordinate multiple robot types and share data between indoor and outdoor fleets. Merger is expected to close in Q3 2026.

Related tickers